US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nxera Pharma Co.,Ltd.

5.44

0.0000

Volume:- -

Turnover:- -

Market Cap:492.29M

PE:-7.65

High:5.44

Open:5.44

Low:5.44

Close:5.44

52wk High:7.20

52wk Low:4.90

Shares:90.49M

Float Shares:73.59M

Volume Ratio:0.70

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7107

EPS(LYR):-0.6184

ROE:-19.35%

ROA:-3.70%

PB:1.25

PE(LYR):-8.80

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Nxera Pharma Co.,Ltd.

Exchange:

PINK LIMITED

Establishment Date:

1990

Employees:

382

Office Location:

Midtown East,9-7-2 Akasaka,Minato,Tokyo,Japan

Website:

http://www.sosei.com

Zip Code:

107-0052

Phone:

Fax:

- -

Introduction:

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SOLTF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SOLTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOLTF\",,,,,undefined,":{"symbol":"SOLTF","market":"US","secType":"STK","nameCN":"Nxera Pharma Co.,Ltd.","latestPrice":5.44,"timestamp":1771621200000,"preClose":5.44,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":73593870,"shares":90494774,"eps":-0.71075,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":5.44,"high":5.44,"low":5.44,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.71075,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":5.44,"volumeRatio":0.7002798178096004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOLTF\",,,,,undefined,":{"symbol":"SOLTF","floatShares":73593870,"roa":"-3.70%","roe":"-19.35%","lyrEps":-0.618397,"volumeRatio":0.7002798178096004,"shares":90494774,"dividePrice":0,"high":5.44,"amplitude":0,"preClose":5.44,"low":5.44,"week52Low":4.9,"pbRate":"1.25","psRate":"2.57","week52High":7.2,"institutionHeld":0,"latestPrice":5.44,"eps":-0.71075,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.71075,"open":5.44,"prevYearClose":5.48,"prevWeekClose":5.44,"prevMonthClose":5.44,"prevQuarterClose":5.48,"fiveDayClose":5.44,"twentyDayClose":5.15,"sixtyDayClose":5.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SOLTF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"SOLTF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715241600000,"name":null,"time":"","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2023-11-10","symbol":"SOLTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699592400000,"reportTimeType":"","actualEps":null},{"date":"2022-11-11","symbol":"SOLTF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668157200000,"name":null,"time":"Pre-Market","dateTimestamp":1668142800000,"actualEps":null},{"market":"US","date":"2022-08-10","symbol":"SOLTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660104000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SOLTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SOLTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771304400000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1266465,"yearFounded":1990,"employeeNum":382,"address":"Midtown East,9-7-2 Akasaka,Minato,Tokyo,Japan","zipCode":"107-0052","officePhone":"81 3 5962 5718"},"stockCompanyDetail":{"websiteUrl":"http://www.sosei.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0917},{"period":"6month","weight":1.0886},{"period":"1year","weight":1.3915},{"period":"ytd","weight":1.3439}],"description":"Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"Nxera Pharma Co.,Ltd.","nameEN":"Nxera Pharma Co.,Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SOLTF\",market:\"US\",,,undefined,":null}}